Similarly, co-expression of hepatocyte growth factor and the Met receptor, described as associated with Met dependency and pazopanib resistance in Yamato-SS cells [17,20,39], correlates with poor prognosis in SS patients [8,20]. The gene discussed is HGF; the disease is synovial sarcoma.